Our President and General Manager, Christopher Stokes, spoke at this year’s Financial Times Global Pharma and Biotech Summit discussing the balance between access and innovation. He emphasised the need for a joined up, ecosystem approach to life sciences, and to evaluate the full social and economic value of medicines. Chris said, “The relationship between incentivising innovation and supporting access is often portrayed as a zero-sum game, but it doesn't have to be. Policies can be designed to encourage both. We need to acknowledge and address the true value that medicines bring to society as a whole. And our industry has an obligation to come to the table with information and evidence that supports this value.” As an industry, we know the pressures the healthcare system is facing, and we want to be part of the solution. Partnerships with industry are an important aspect of that. Through working in partnership, we hope to not only incentivise innovation and support equitable access but address the true impact of diseases on patients, their families, and the economy. #WeAreLillyUKandIreland
Allan Robinson
1mo
Well said! It doesn't need to be!;
Erika Hardy
1mo
Continue to soar my friend!
Paul Titus
1mo
Well done my friend! Look at you fly!
Chad Thieman
1mo
Stokes …. I am proud of all your accomplishments.. keep up the amazing work !!!
Tim Moore
1mo
Chris Stokes is a wise man
Tyler Putnam
1mo
Good to see you Chris, thank you for the best Sony speaker ever!!!
Well said Chris!
Great work Chris! I’m proud of you my man.
Senior Administrative Assistant at Lilly USA, LLC
1moFrom an outsider; well said. Keep moving ahead.